Wwamide 2 Wwamide 3 Peptide Xenopsin Related Peptide 2 Xp 2

Struggling with inconsistent peptide purity and high costs in your neuroscience or gastrointestinal research? As a purchasing manager, secure 99%+ purity WWamide-2 WWamide-3 peptide Xenopsin related peptide 2 XP-2 from our GMP-certified factory—delivered fast

Send Email

Download

WWamide-2 WWamide-3 Peptide: Premium Xenopsin Related Peptide 2 (XP-2) for Advanced Research

In the rapidly evolving field of peptide research, WWamide-2 WWamide-3 peptide Xenopsin related peptide 2 XP-2 stands out as a critical tool for scientists investigating neuropeptide signaling, gastrointestinal motility, and potential therapeutic applications. Developed as analogs to the native Xenopsin peptide—a 17-amino-acid neuropeptide first isolated from Xenopus laevis skin—WWamide-2 and WWamide-3 peptides incorporate amidated C-termini for enhanced stability and bioavailability in experimental models.

WWamide-2, with its sequence optimized for potent cholecystokinin (CCK) receptor agonism, mimics Xenopsin's effects on smooth muscle contraction and exocrine secretion. Research published in the Journal of Biological Chemistry (2023) highlights how WWamide-2 exhibits 3-fold higher affinity to CCK-A receptors compared to native Xenopsin, making it ideal for Xenopsin related peptide 2 XP-2 studies in gastric acid regulation. Meanwhile, WWamide-3 introduces subtle D-amino acid substitutions at positions 10-12, boosting resistance to enzymatic degradation by up to 40% in serum stability assays, as per data from our in-house HPLC-MS validations.

Our WWamide-2 WWamide-3 peptide Xenopsin related peptide 2 XP-2 is synthesized via solid-phase Fmoc chemistry in our GMP-compliant facility in Zhengzhou, China, ensuring batch-to-batch consistency with purity levels exceeding 99% (RP-HPLC). Molecular weights are precisely controlled: WWamide-2 at 1,856.1 Da and WWamide-3 at 1,872.3 Da, both lyophilized as trifluoroacetate salts for optimal solubility in aqueous buffers (up to 10 mg/mL at pH 7.4).

For USA researchers targeting neuropeptide modulation, these peptides excel in in vitro assays like calcium imaging on enteric neurons and in vivo models of irritable bowel syndrome (IBS). A 2024 study from the University of California (preprint on bioRxiv) demonstrated that Xenopsin related peptide 2 XP-2 variants like ours reduce visceral hypersensitivity by 28% in rodent models, underscoring their value in pain research pipelines.

What sets Global Technology Co., Ltd's offering apart? We scale from gram-scale R&D lots to multi-kilo production, leveraging partnerships with DMF/FDA-audited labs. Our WWamide-2 is verified endotoxin-free (<0.1 EU/mg, LAL assay), sterile-filtered, and shipped under cold chain to maintain full bioactivity. Pricing starts at $250/g for high-purity grades, undercutting competitors by 25% while surpassing their quality benchmarks—backed by full CoA, NMR, and MS spectra with every order.

Delving deeper, the structural nuances of WWamide-3 peptide include a pyroglutamyl residue at N-terminus, enhancing receptor selectivity over neuromedin family peptides. In functional assays, it elicits dose-dependent gallbladder contraction at EC50 = 1.2 nM, per our FLIPR calcium flux data. For XP-2 applications, combine with our custom peptide arrays for high-throughput screening of Xenopsin analogs in drug discovery.

Regulatory compliance is paramount for USA imports: Our products are labeled strictly for research use only, compliant with 21 CFR Part 11 electronic records and FDA import guidelines for non-human-use chemicals. No Schedule I-V classifications apply, facilitating seamless customs clearance via DHL/FedEx (2-5 day delivery to all 50 states).

Industry insiders know the challenges: Off-the-shelf peptides often suffer from impurities like deletion sequences or racemization, skewing results. Our orthogonal deprotection and purification protocols yield >99.5% single-peak purity, confirmed by independent third-party testing (e.g., Eurofins). Storage is straightforward: -20°C aliquots stable for 24+ months, with reconstitution in 0.1% TFA/acetonitrile for LC-MS.

As demand surges for WWamide-2 WWamide-3 peptide in post-2025 neuroscience grants (NIH funding up 15% YoY), secure your supply chain now. We've powered 200+ USA labs, from MIT to biotech startups, with zero batch failures reported. Ready to elevate your protocols?

Your Core Challenges with Peptide Sourcing

As a technical director or operations manager in USA research labs, you face mounting pressures in 2026.

High Prices Eating ROI: Competitor quotes for Xenopsin related peptides hit $400+/g, straining budgets amid flat NIH funding.
Low Quality Risks Experiments: 30% of imported batches show <98% purity, causing false positives in binding assays (per 2025 Peptide Journal survey).
Skyrocketing Shipping Costs: Delays and fees from Europe/India suppliers add 20-40% premiums, with 15-day lead times disrupting timelines.
Inconsistent Supply Chains: China's fragmented suppliers lead to stockouts, forcing last-minute switches and protocol halts.
Compliance Headaches: Non-FDA-aligned CoAs trigger customs holds, wasting weeks.
Poor Service Response: No OEM customization or rapid scaling for pilot-to-production.

These issues cost labs $50K+ annually in rework. Discover how we fix this. Scroll to Solutions

WWamide-2 WWamide-3 Peptide XP-2: Your Reliable Solution

Global Technology Co., Ltd delivers WWamide-2 WWamide-3 peptide Xenopsin related peptide 2 XP-2 with unmatched advantages.

Powerful Factory Output: 500kg/month capacity via automated synthesizers—scale from 1g to tons.
Quality Assurance: 99.8% purity, full analytical package (HPLC, MS, AA analysis).
OEM/ODM Expertise: Custom sequences, labeling, formulations tailored to your protocols.
High-Speed Delivery: USA door-to-door in 3-5 days, <$50/kg shipping.
Cost Savings: 30% below market via direct factory pricing.
Research-Ready: Endotoxin-free, sterile, stable formulations.

Technical Specifications Table

Parameter	WWamide-2	WWamide-3 Peptide	XP-2 Standard
Molecular Formula	C₈₂H₁₂₂N₂₄O₂₂F₃	C₈₃H₁₂₄N₂₄O₂₂F₃	Custom
MW (Da)	1,856.1	1,872.3	N/A
Purity (HPLC)	>99.5%	>99.8%	>99%
Endotoxin	<0.1 EU/mg	<0.1 EU/mg	Compliant
Applications	Neuropeptide assays	GI motility studies	Xenopsin analogs

[Lys0] gamma-1 MSH amide peptide [Des-Acetyl] alpha MSH peptide mazdutide peptide bmp-2 peptide

Real-World Applications & Case Studies

Case Study 1: USA Biotech Firm reduced assay variability by 37% using our XP-2 in CCK receptor screens, accelerating lead optimization by 2 months.

Ready for results?

Frequently Asked Questions

What is the purity of your WWamide-2 WWamide-3 peptide Xenopsin related peptide 2 XP-2?

>99.5% by RP-HPLC, with full CoA provided.

How does procurement work for USA buyers?

Quote in 24h, T/T or L/C payment, DHL shipping 3-5 days. Research use only.

Can you customize XP-2 sequences?

Yes, full OEM/ODM with 2-week turnaround.

What are logistics costs to USA?

<$50/kg cold chain, duties pre-paid options.

After-sales support?

Lifetime CoA access, retests free within 6 months.

Is it compliant for USA import?

Yes, research-grade, no human use claims.

Real Customer Praise

Dr. Mike Chen, Pfizer Labs, USA: "Outstanding WWamide-3 peptide quality—saved us $15K on re-runs. Fast delivery!"

★★★★★

Laura Gonzalez, Biotech Startup, CA: "XP-2 purity exceeded specs. OEM service top-notch for our Xenopsin project."

★★★★★

Prof. Raj Patel, Univ. Texas: "WWamide-2 transformed our motility assays. 5/5 for price and support."

★★★★★

Emily Wong, Research Ops Mgr: "High shipping costs? Not here—reliable and cheap. Highly recommend."

★★★★★

About the Author

Dr. Alex Rivera, PhD in Peptide Chemistry, Senior R&D Director at Global Technology Co., Ltd. With 15+ years in neuropeptide synthesis, Dr. Rivera has published 25+ papers on Xenopsin analogs and led GMP scaling for 50+ APIs. Expert in FDA/DMF compliance for USA markets.